FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

70562007: Leuprorelin acetate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
117207019 Leuprolide acetate en Synonym Active Entire term case insensitive SNOMED CT core module
117208012 Leuprorelin acetate en Synonym Active Entire term case insensitive SNOMED CT core module
3720080013 Leuprorelin acetate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Leuprorelin acetate Is a Acetate false Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Medicinal product acting as antineoplastic agent (product) false Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Leuprorelin false Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Acetate compound false Inferred relationship Existential restriction modifier
Leuprorelin acetate Has disposition Hypothalamic releasing factor true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is modification of Leuprorelin true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Gonad regulating hormone agent true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Gonadotropin releasing factor true Inferred relationship Existential restriction modifier
Leuprorelin acetate Is a Hypothalamic releasing factor false Inferred relationship Existential restriction modifier
Leuprorelin acetate Has disposition Gonad regulating hormone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Leuprorelin acetate Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 3.75mg powder for injection solution + diluent Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 11.25mg injection powder for injection solution + diluent Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 3.75mg/vial powder Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 7.5mg powder for injection suspension vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 22.5mg powder for injection suspension vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 30mg powder for injection suspension vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 11.25mg powder for injection suspension vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 3.75mg injection Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 15mg powder and solvent for injection suspension vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 5mg/mL injection solution 0.2mL ampule Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 30mg Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 3.75mg/vial powder for injection Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 65mg implant Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 3.75mg powder for injection solution + diluent Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 11.25mg injection powder for injection solution + diluent Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 3.75mg/vial powder Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 45mg powder for injection suspension vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 15mg powder for injection suspension vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 11.25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 11.25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 3.75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 3.75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 7.5 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 7.5 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 20 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 20 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 60 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 60 milligram/1 milliliter conventional release suspension for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 7.5 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 7.5 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 45 milligram/1 syringe powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 45 milligram/1 syringe powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 30 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has precise active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Product containing precisely leuprorelin acetate 30 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has basis of strength substance True Leuprorelin acetate Inferred relationship Existential restriction modifier 1
Prostap SR DCS 3.75mg powder and solvent for suspension for injection pre-filled syringes (Pilsco Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR DCS 3.75mg powder and solvent for suspension for injection pre-filled syringes (Pilsco Ltd) 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin acetate 3.75mg injection (pdr for recon)+diluent+kit - product Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin acetate 11.25mg injection (pdr for recon)+diluent - product Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg injection (pdr for recon)+diluent+kit Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 injection (pdr for recon)+diluent Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 10.72mg implant pre-filled syringes Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Staladex 10.72mg implant pre-filled syringes (Typharm Ltd) 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Staladex 10.72mg implant pre-filled syringes (Typharm Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 10.72mg implant pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (CST Pharma Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (CST Pharma Ltd) 1 pre-filled disposable injection Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Wyeth Laboratories) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Wyeth Laboratories) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection vial 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 11.25mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Wyeth Laboratories) 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Wyeth Laboratories) 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) 1 vial Has active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection vial 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 3.75mg powder for injection solution + diluent Has specific active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Wyeth Laboratories) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Wyeth Laboratories) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprorelin 11.25mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Leuprolide acetate 11.25mg injection powder for injection solution + diluent Has specific active ingredient False Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Wyeth Laboratories) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Wyeth Laboratories) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) 1 vial Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Mawdsley-Brooks & Company Ltd) Has active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier
Prostap 3 Depot 11.25mg powder and solvent for suspension for injection vials (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Leuprorelin acetate Inferred relationship Existential restriction modifier

Page 1 of 2 End

This concept is not in any reference sets

Back to Start